| 000 | 01662 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513204030.0 | ||
| 264 | 0 | _c20000425 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/ajrccm.161.3.9904094 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujii, Y | |
| 245 | 0 | 0 |
_aEndothelin receptor blockade attenuates lipopolysaccharide-induced pulmonary nitric oxide production. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cMar 2000 |
||
| 300 |
_a982-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelin-1 _xphysiology |
| 650 | 0 | 4 |
_aEscherichia coli _ximmunology |
| 650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aLipopolysaccharides _ximmunology |
| 650 | 0 | 4 |
_aLung _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Endothelin A |
| 650 | 0 | 4 |
_aReceptors, Endothelin _xphysiology |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _xphysiopathology |
| 700 | 1 | _aMagder, S | |
| 700 | 1 | _aCernacek, P | |
| 700 | 1 | _aGoldberg, P | |
| 700 | 1 | _aGuo, Y | |
| 700 | 1 | _aHussain, S N | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 161 _gno. 3 Pt 1 _gp. 982-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/ajrccm.161.3.9904094 _zAvailable from publisher's website |
| 999 |
_c10666326 _d10666326 |
||